Literature DB >> 19923875

The relationships between adverse events, early antecedents, and carbon dioxide reactivity as an intermediate phenotype of panic disorder: a general population study.

Anna Ogliari1, Kristian Tambs, Jennifer R Harris, Simona Scaini, Cesare Maffei, Ted Reichborn-Kjennerud, Marco Battaglia.   

Abstract

BACKGROUND: Although adverse events have been consistently described to precede and potentially precipitate the onset of panic disorder, there is no information about their ability to alter the individual reactivity to inhaled carbon dioxide, a putative intermediate phenotype of susceptibility to panic disorder.
METHOD: Seven-hundred twelve subjects belonging to the general population-based Norwegian Institute of Public Health Twin Panel underwent a 35% CO(2)/65% O(2) inhalation challenge test and interview-based lifetime assessments of DSM-IV panic disorder, separation anxiety disorder, childhood parental separation/loss, major life events, adverse events of suffocative nature and common stressful life events. Regression models were applied to predict global subjective anxiety and DSM-IV panic symptoms after 35% CO(2)/65% O(2) inhalation.
RESULTS: The responses to the challenge measured as semicontinuous variables were predicted by symptoms of childhood separation anxiety, childhood parental loss, common stressful events, major life events, suffocative events and the female gender. The role of most of these predictors was confirmed and held true after the exclusion of subjects with lifetime panic attacks/disorder from the analyses.
CONCLUSIONS: Several factors which have been reported by previous clinical studies to influence the individual susceptibility to develop panic disorder seem to affect the individual reactivity to inhaled carbon dioxide in people from the general population. Some elements of risk may impact simultaneously upon the individual liability to panic and exaggerated sensitivity to hypercapnia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923875     DOI: 10.1159/000259417

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  6 in total

1.  Evidence for distinct genetic effects associated with response to 35% CO₂.

Authors:  Roxann Roberson-Nay; Sara Moruzzi; Anna Ogliari; Elettra Pezzica; Kristian Tambs; Kenneth S Kendler; Marco Battaglia
Journal:  Depress Anxiety       Date:  2013-01-24       Impact factor: 6.505

2.  Exposure assessment of potash miners at elevated CO2 levels.

Authors:  Christian Monsé; Horst Christoph Broding; Kirsten Sucker; Hans Berresheim; Birger Jettkant; Frank Hoffmeyer; Rolf Merget; Thomas Brüning; Jürgen Bünger
Journal:  Int Arch Occup Environ Health       Date:  2013-04-23       Impact factor: 3.015

3.  Unstable maternal environment, separation anxiety, and heightened CO2 sensitivity induced by gene-by-environment interplay.

Authors:  Francesca R D'Amato; Claudio Zanettini; Valentina Lampis; Roberto Coccurello; Tiziana Pascucci; Rossella Ventura; Stefano Puglisi-Allegra; Chiara A M Spatola; Paola Pesenti-Gritti; Diego Oddi; Anna Moles; Marco Battaglia
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

Review 4.  Separation anxiety: at the neurobiological crossroads of adaptation and illness.

Authors:  Marco Battaglia
Journal:  Dialogues Clin Neurosci       Date:  2015-09       Impact factor: 5.986

5.  Evidence that the periaqueductal gray matter mediates the facilitation of panic-like reactions in neonatally-isolated adult rats.

Authors:  Jeyce Willig Quintino-dos-Santos; Cláudia Janaína Torres Müller; Cristie Setúbal Bernabé; Caroline Azevedo Rosa; Sérgio Tufik; Luiz Carlos Schenberg
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

6.  Disruption of estradiol regulation of orexin neurons: a novel mechanism in excessive ventilatory response to CO2 inhalation in a female rat model of panic disorder.

Authors:  Luana Tenorio-Lopes; Stéphanie Fournier; Mathilde S Henry; Frédéric Bretzner; Richard Kinkead
Journal:  Transl Psychiatry       Date:  2020-11-10       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.